CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 35 filers reported holding CONMED CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $214,832 | +602.1% | 185,000 | +825.0% | 0.00% | – |
| Q2 2023 | $30,600 | -95.1% | 20,000 | -96.1% | 0.00% | – |
| Q1 2023 | $622,850 | +8.1% | 507,000 | 0.0% | 0.00% | – |
| Q4 2022 | $575,942 | +17.5% | 507,000 | +11.7% | 0.00% | – |
| Q3 2022 | $490,000 | +716.7% | 454,000 | +808.0% | 0.00% | – |
| Q2 2022 | $60,000 | +200.0% | 50,000 | +284.6% | 0.00% | – |
| Q3 2021 | $20,000 | +300.0% | 13,000 | +333.3% | 0.00% | – |
| Q2 2021 | $5,000 | -28.6% | 3,000 | -25.0% | 0.00% | – |
| Q1 2021 | $7,000 | -98.2% | 4,000 | -98.6% | 0.00% | – |
| Q4 2020 | $386,000 | +26.1% | 277,000 | 0.0% | 0.00% | – |
| Q3 2020 | $306,000 | -78.8% | 277,000 | -79.9% | 0.00% | – |
| Q2 2020 | $1,445,000 | +56.2% | 1,380,000 | +38.0% | 0.00% | – |
| Q1 2020 | $925,000 | – | 1,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 50,065,000 | $86,599,000 | 6.97% |
| III Capital Management | 12,488,000 | $21,464,000 | 1.87% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $6,946,000 | 1.55% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,082,000 | $10,261,000 | 1.29% |
| SSI INVESTMENT MANAGEMENT LLC | 6,448,000 | $11,078,000 | 0.60% |
| MACKAY SHIELDS LLC | 38,008,000 | $65,472,000 | 0.58% |
| Eisler Capital (UK) Ltd. | 9,500,000 | $16,280,000 | 0.27% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 53,974,000 | $93,024,000 | 0.26% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 2,607,000 | $4,493,000 | 0.25% |
| Polar Asset Management Partners Inc. | 10,000,000 | $17,137,000 | 0.18% |